흰쥐 가슴샘 재생과정에서 IL-17A의 발현 특성
Expression of IL-17A during Thymus Regeneration in the Rat
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
IL-17A는 활성화된 T 세포에 의해 분비되는 사이토카인으로 5개의 연관된 사이토카인인 IL-17B, IL-17C, IL-17D, IL-17E 및 IL-17F과 함께 IL-17 family로 분류되며, 이들은 모두 유사한 단백질 구조를 가지고 있다. IL-17A와 IL-17F는 활성화된 T 세포에서 발현되는 반면 IL-17B, IL-17C, IL-17D 및 IL-17E는 모든 조직에서 광범위하게 발현되며 이들의 기능은 IL-17A와 부분적으로 일치하지만 이에 관해서 자세히 연구되어 있지않다. 가슴샘버팀질세포는 가슴샘세포의 증식, 성숙 및 분화의 조절에 중요한 역할을 하는 것으로 알려져 있기 때문에, 본 연구에서는 가슴샘세포, 가슴샘상피세포, 큰포식세포, 가슴샘가지돌기세포 및 가슴샘종양세포에서 역전사 중합효소 연쇄반응법을 이용하여 IL-17 family의 발현 특성을 확인하였다. 또한 cyclophosphamide를 흰쥐에투여하여 가슴샘의 급성 퇴축을 유발시킨 다음 3, 7 및 14일째 실험 동물을 희생시켜, 가슴샘 재생과정 동안 시간의 경과에 따른 IL-17 family와 IL-17 수용체(IL-17R)의 발현특성을 역전사 중합효소 연쇄반응법을 통해 조사하였으며, IL-17A의 경우는 면역조직화학법을 이용하여 그 발현양상을 더 구체적으로 분석하였다. 그 결과IL-17A와 IL-17E는 가슴샘종양세포에서만 발현되었고 IL-17C는 큰포식세포를 제외한 모든 세포에서 발현되고있음을 확인하였다. IL-17F의 경우 실험군의 모든 세포에서 발현된 반면에 IL-17B와 IL-17D는 전혀 발현되지않았다. 또한 IL-17A는 가슴샘 재생과정 중 가슴샘세포와 가슴샘버팀질세포에서 모두 증가되었으며 IL-17A의수용체인 IL-17R은 재생모델의 가슴샘세포와 가슴샘버팀질세포에서 발현양이 거의 유사하였다. 면역조직화학법을 이용한 분석에서도 재생과정 동안 상피세포에서 IL-17A의 발현이 증가됨을 확인하였다. 따라서 가슴샘세포와 가슴샘 상피세포에서 IL-17A의 발현 및 그 수용체를 통한 신호전달은 가슴샘의 급성퇴축 이후 가슴샘이 재생되는 과정에 중요한 역할을 할 것으로 생각된다.
Abstract
IL-17A is a pro-inflammatroy cytokine secreted by activated T cells. The IL-17 family consist of IL-17A, IL-17B, IL-17C, IL-17D, IL-17E and IL-17F. IL-17A and IL-17F are produced primarily in activated T cells. In contrast, IL-17B, IL-17C, IL-17D and IL-17E are expressed in a wide assortment of tissues. Their functions partially overlap those of IL-17A, although they have not been as thoroughly investigated. The receptor for IL-17A (IL-17R) is widely expressed in a variety of tissues. IL-17A and IL-17E mRNAs were expressed in only EL4 cells. IL-17C mRNA expression was observed in the thymic subcapsular/cortex epithelial cells (SNEC), cortex or cortical reticular cells (CREC), medullary epithelial cells (MEC), medullary interdigitating-like cells (MDC), thymocytes and EL4 cells. However, IL-17C mRNA was not expressed in RAW 264.7 cells. Immunohistochemical study also demonstrated not only the presence of IL-17A mainly in the thymic epithelial cells, but also the upregulated expression of IL-17A in the thymic epithelial cells of the regenerating thymus. Thus, the results of the present study suggest that IL-17A expressed in the thymocytes and thymic epithelial cells could play an important role in the development of new T cells to replace T cells damaged by cyclophosphamide treatment during thymus regeneration.
참고문헌 (67)
- Anderson G, "Cellular interaction in thymocyte development", Annu Rev Immunol, 14, pp.73~99 (1996)
- Attur MG, "Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage", Arthritis Rheum, 40, pp.1050~1053 (1997)
- Benchetrit F, "Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism", Blood, 99, pp.2114~2121 (2002)
- Boyd RL, "The thymic microenvironment", Immunol Today, 13, pp.445~459 (1993)
- Brock N, "New nitrogen mustard phosphamide esters and their cytostatic activity", Laval Med, 39, pp.696~701 (1968)
- Cai L, "Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown", J Rheumatol, 29, pp.1725~1736 (2002)
- Cai L, "Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo", 16, pp.~21 (2001)
- Chabaud M, "Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium", Arthritis Rheum, 42, pp.963~970 (1999)
- Chabaud M, "Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines", J Immunol, 161, pp.409~414 (1998)
- Chabaud M, "Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis", Cytokine, 12, pp.1092~1099 (2000)
- Chabaud M, "IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis", Arthritis Res, 3, pp.168~177 (2001)
- Chen WF, "Multiple types of cytokines constitutively produced by an established murine thymic epithelial cell line", Eur Cytokine Nets, 3, pp.43~52 (1992)
- Dalloul AH, "Human thymic epithelial cells produce interleukin-3", Blood, 77, pp.69~74 (1991)
- Draber P, "Nuclear and functional characterization of lymphocytes following cyclophosphamide treatment", Folia Biol, 23, pp.158~169 (1977)
- Faas SJ, "Phenotypically diverse mouse thymic stromal cell lines which induce proliferation and differentiation of hematopoietic cells", Eur J Immunol, 23, pp.1201~1214 (1993)
- Fossiez F, "T cell interleukin- 17 induces stromal cells to produce proinflammatory and hematopoietic cytokines", J Exp Med, 183, pp.2593~2603 (1996)
- Gaffen SL, "Structure and signalling in the IL-17 receptor family", Nat Rev Immunol, 9, pp.556~567 (2009)
- Geenen V, "The thymus as a neuroendocrine organ. Synthesis of vasopressin and oxytocin in human thymic epithelium", Ann NY Acad Sci, 496, pp.56~66 (1987)
- Haynes BF, "The human thymic microenvironment", Adv Immunol, 36, pp.87~142 (1984)
- Helle M, "IL-6 is an intermediate in IL-1 induced thymocyte proliferation", J Immunol, 142, pp.4335~4338 (1989)
- Hirahara N, "Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice", Oncology, 61, pp.79~89 (2001)
- Hirahara N, "Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene", Anticancer Res, 20, pp.3137~3142 (2000)
- Hirata H, "Production of TARC and MDC by naïve T cells in asthmatic patients", J Clin Immunol, 23, pp.34~45 (2003)
- Hofmann WJ, "Thymic hyperplasia. I. True thymic hyperplasia. Review of the literature", Klin Wochenschr, 65, pp.49~52 (1987)
- Hows JM, "Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study", Br J Cancer, 50, pp.753~756 (1984)
- Hymowitz SG, "IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding", EMBO J, 20, pp.5332~5341 (2001)
- Jovanovic DV, "IL-17 Stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages", J Immunol, 160, pp.3513~3521 (1998)
- Kakinuma T, "High level of thymus and activationregulated chemokine in blister fluid and sera of patients with bullous pemphigoid", Br J dermatol, 148, pp.203~210 (2003)
- Kasahara Y, "Role of interleukin 6 for differential responsiveness of nave and memory CD4+ T-cells in CD2-mediated activation", J Exp Med, 172, pp.1419~1424 (1990)
- Kato T, "Expression of IL-17 mRNA in ovarian cancer", Biochem Biophys Res Commun, 282, pp.735~738 (2001)
- Katz Y, "Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1, 6 and 8 in skin and synovial fibroblasts: a possible role as a “fine-tuning cytokine” in inflammation processes", Arthritis Rheum, 44, pp.2176~2184 (2001)
- Kendall MD, "Funcional anatomy of the thymic microenviroment", J Anat, 177, pp.1~29 (1991)
- Kurasawa K, "Increased interleukin- 17 production in patients with systemic sclerosis", Arthritis Rheum, 43, pp.2455~2463 (2000)
- Kurz B, "Calcitonin gene-related peptide and its receptor in the thymus", Peptides, 16, pp.1497~1503 (1995)
- Laan M, "Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways", J Immunol, 162, pp.2347~2352 (1999)
- Le PT, "Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors", Immunol, 141, pp.1211~1217 (1988)
- Le PT, "Regulation of cytokine production in the human thymus: epidermal growth factor and transforming growth factor alpha regulate mRNA levels of interleukin 1alpha (IL-1 alpha), IL-1 beta, and IL-6 in human thymic epithelial cells at a post-transcriptional level", 174, pp.1147~1157 (1991)
- Le PT, "Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor", J Immunol, 145, pp.3310~3315 (1990)
- Lee CK, "A mouse thymic stromal cell line producing macrophage-colony stimulating factor and interleukin-6", Arch Pharm Res, 23, pp.252~256 (2000)
- Liu Y, "IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro", J Immunol, 186, pp.3197~3205 (2011)
- Moseley TA, "Interleukin-17 family and IL-17 receptors", Cytokine Growth FactorRev, 14, pp.155~174 (2003)
- Nanno M, "Production of granulocytemacrophage colony-stimulating factor or GM-CSFlike growth factor by rat thymic epithelial cell line", JLeukoc Biol, 50, pp.561~567 (1991)
- Oda N, "Suplatast tosilate inhibits thymus and activation-regulated chemokine production by antigen-specific human Th2 cells", Clin Exp Allergy, 32, pp.1782~1786 (2002)
- Pages F, "Control of tumor development by intratumoral cytokines", ImmunolLett, 68, pp.135~139 (1999)
- Reynolds JEF, "Martindale: The Extra Pharmacopeia", pp.199~ (1982), The Parmaceutical Press
- Rifas L, "novel T cell cytokine stimulates interleukin- 6 in human osteoblastic cells", J Bone MinerRes, 14, pp.1096~1103 (1999)
- Rouse RV, "Monoclonal antibodies reactive with subsets of mouse and human thymic epithelial cells", J Histochem Cytochem, 36, pp.1511~1517 (1988)
- Rouvier E, "CTLA-8, cloned from an activated T cell, bearing AUrich messenger RNA instability sequences, and homologous to a Herpesvirus saimiri gene", J Immunol, 150, pp.5445~5456 (1993)
- Savino W, "Extracellular matrix proteins in intrathymic T celll migration and differentiation", Immunol Today, 14, pp.158~161 (1993)
- Schuurman HJ, "Thymic microenvironment at the light microscopic level", Microsc Res Tech, 38, pp.216~226 (1997)
- Schwarzenberger P, "Requirement of endogenous stem cell factor and granulocyte-colonystimulating factor for IL-17-mediated granulopoiesis", J Immunol, 164, pp.4783~4789 (2000)
- Shalom-Barak T, "Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogenactivated protein kinases and NF-κB", J Biol Chem, 273, pp.27467~27473 (1998)
- Sladek NE, "Metabolism of cyclophoshamide by rat hepatic microsomes", Cancer Res, 31, pp.901~908 (1971)
- Starnes T, "Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production", J Immunol, 167, pp.4137~4140 (2001)
- Tartour E, "Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice", Cancer Res, 59, pp.3698~3704 (1999)
- Teunissen MB, "Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes", J Invest Dermatol, 111, pp.645~649 (1998)
- Tokuda H, "nterleukin (IL)-17 enhances prostaglandin F2α-stimulated IL-6 synthesis in osteoblasts", Prostaglandins Leukot Essent Fatty Acids, 66, pp.427~433 (2002)
- Tokuda N, "Expression of PAC1 receptor in rat thymus after irradiation", RegulPept, 123, pp.167~172 (2004)
- Wang GJ, "Relatively low-dose cyclophosphamide is likely to induce apoptotic cell death in rat thymus through Fas", Fas ligand pathway, 1999, pp.427, 125~133
- Witowski J, "IL-17 stimulates intra-peritoneal neutrophil infiltration through the release of GRO a chemokine from mesothelial cells", JImmunol, 165, pp.5814~5821 (2000)
- Wurbel MA, "Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T-and B-cell development and a reduction in T-cell receptor γδ+ gut intraepithelial lymphocytes", Blood, 98, pp.2626~2632 (2001)
- Wurbel MA, "The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double-and single-positive thymocytes expressing the TECK receptor CCR9", EurJ Immunol, 30, pp.262~271 (2000)
- Yao Z, "Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor", Immunity, 3, pp.811~821 (1995)
- Yao Z, "Mole-cular characterization of the human interleukin (IL)- 17 receptor", Cytokine, 9, pp.794~800 (1997)
- Yao Z, "Complete nucleotide sequence of the mouse CTLA8 gene", Gene, 168, pp.223~225 (1996)
- Yoon S, "Ultrastructural alterations of the cortical epithelial cells of the rat thymus after cyclophosphamide treatment", Histol Histopathol, 12, pp.401~413 (1997)
- Ziolkowska M, "High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism", J Immunol, 164, pp.2832~2838 (2000)
